Literature DB >> 27500538

Overlapping meta-analyses of bioresorbable vascular scaffolds versus everolimus-eluting stents: bringing clarity or confusion?

Davide Capodanno1.   

Abstract

Entities:  

Year:  2016        PMID： 27500538      PMCID： PMC4958870          DOI： 10.21037/jtd.2016.05.14

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.

Authors:  Serban Puricel; Diego Arroyo; Noé Corpataux; Gérard Baeriswyl; Sonja Lehmann; Zacharenia Kallinikou; Olivier Muller; Ludovic Allard; Jean-Christophe Stauffer; Mario Togni; Jean-Jacques Goy; Stéphane Cook
Journal:  J Am Coll Cardiol       Date:  2015-03-03       Impact factor: 24.094

2.  Observations from the recent FDA Circulatory System Devices Panel meeting on bioresorbable vascular scaffolds.

Authors:  Patrick W Serruys
Journal:  EuroIntervention       Date:  2016-04-08       Impact factor: 6.534

3.  Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.

Authors:  Yoshinobu Onuma; Dariusz Dudek; Leif Thuesen; Mark Webster; Koen Nieman; Hector M Garcia-Garcia; John A Ormiston; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2013-10       Impact factor: 11.195

Review 4.  Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Sebastian Kufner; Jens Wiebe; Janika Repp; Heribert Schunkert; Massimiliano Fusaro; Takeshi Kimura; Adnan Kastrati
Journal:  Lancet       Date:  2015-11-17       Impact factor: 79.321

Review 5.  Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.

Authors:  Si-Hyuck Kang; In-Ho Chae; Jin-Joo Park; Hak Seung Lee; Do-Yoon Kang; Seung-Sik Hwang; Tae-Jin Youn; Hyo-Soo Kim
Journal:  JACC Cardiovasc Interv       Date:  2016-06-01       Impact factor: 11.195

6.  Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Authors:  Stephen G Ellis; Dean J Kereiakes; D Christopher Metzger; Ronald P Caputo; David G Rizik; Paul S Teirstein; Marc R Litt; Annapoorna Kini; Ameer Kabour; Steven O Marx; Jeffrey J Popma; Robert McGreevy; Zhen Zhang; Charles Simonton; Gregg W Stone
Journal:  N Engl J Med       Date:  2015-10-12       Impact factor: 91.245

Review 7.  Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.

Authors:  Michael J Lipinski; Ricardo O Escarcega; Nevin C Baker; Hadiya A Benn; Michael A Gaglia; Rebecca Torguson; Ron Waksman
Journal:  JACC Cardiovasc Interv       Date:  2016-01-11       Impact factor: 11.195

8.  Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents: Insights from randomized trials.

Authors:  Sripal Bangalore; Bora Toklu; Deepak L Bhatt
Journal:  Int J Cardiol       Date:  2016-03-22       Impact factor: 4.164

9.  Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Authors:  Manel Sabaté; Stephan Windecker; Andres Iñiguez; Lisette Okkels-Jensen; Angel Cequier; Salvatore Brugaletta; Sjoerd H Hofma; Lorenz Räber; Evald Høi Christiansen; Maarten Suttorp; Thomas Pilgrim; Gerrit Anne van Es; Yohei Sotomi; Hector M García-García; Yoshinobu Onuma; Patrick W Serruys
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

10.  A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.

Authors:  Takeshi Kimura; Ken Kozuma; Kengo Tanabe; Sunao Nakamura; Masahisa Yamane; Toshiya Muramatsu; Shigeru Saito; Junji Yajima; Nobuhisa Hagiwara; Kazuaki Mitsudo; Jeffrey J Popma; Patrick W Serruys; Yoshinobu Onuma; Shihwa Ying; Sherry Cao; Peter Staehr; Wai-Fung Cheong; Hajime Kusano; Gregg W Stone
Journal:  Eur Heart J       Date:  2015-09-01       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.